COMPUMEDICS LIMITED — Regulatory Filings 2017

Apr 3, 2017

==> picture [502 x 118] intentionally omitted <==

Company Announcement

Compumedics Corporate Video Now Online

4 April 2017

Compumedics Limited (ASX: CMP) (Compumedics) is pleased to provide shareholders with the Company’s recently released corporate video, which can be accessed here.

This corporate video is currently being used in roadshow meetings, along with the corporate presentation, which was released with the half year results, on 28 February 2017.

About Compumedics Limited

Compumedics Limited [ASX: CMP] is a medical device company involved in the development, manufacture and commercialisation of diagnostics technology for the sleep, brain and ultrasonic blood-flow monitoring applications. The company owns US based Neuroscan and Germany based DWL Elektronishe GmbH. In conjunction with these two subsidiaries, Compumedics has a broad international reach, including the Americas, Australia and Asia Pacific, Europe and the Middle East.

Executive Chairman Dr David Burton founded Compumedics in 1987. In the same year the company successfully designed and installed the first Australian, fully computerised sleep clinic at Epworth Hospital in Melbourne. Following this early success, Compumedics focused on the development of products that sold into the growing international sleep clinic and home monitoring markets.

Compumedics listed on the Australian Securities Exchange in 2000. Over the years, Compumedics has received numerous awards, including Australia’s Exporter of the Year, and has been recognised as a Top 100 Innovator by both German and Australian governments.

For further information please contact: Dr David Burton

Executive Chairman, CEO Executive Director Ph: + 61 3 8420 7300 Fax: + 61 3 8420 7399

David Lawson

Director and Chief Financial Officer Ph: + 61 3 8420 7300 Fax: +61 3 8420 7399

Investor Relations, Media & PR enquires:

Rod North

Managing Director Bourse Communications Pty Ltd Ph: +61 3 9510 8309 M: 0408 670 706

Richard Allen

Oxygen Financial PR

Ph: + 61 3 9915 6341 M: 0403 493 049